StockSelector.com
  Research, Select, & Monitor Friday, April 26, 2019 8:34:40 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Pfizer, Inc.$39.61$.24.61%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Pfizer, Inc. has an overall rank of 4944 out of 6905 stocks based on 12 positive rankings and 12 negative rankings.

Positive Rankings
Positive Stoch Cross
Pfizer rank is 179
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, Pfizer is ranked 259.
Top Industry Values
Pfizer rank is 415
Highest Net Margin
Pfizer rank is 796
Highest ROE
Pfizer rank is 848
Target Prices
The average analysts' target price is $41.00 for Pfizer using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Pfizer is ranked 946.
Highest ROA
Pfizer rank is 995
Estimated EPS Growth
Pfizer rank is 1187
Historic EPS Growth
Pfizer rank is 1385
SSValue
The StockSelector Value for Pfizer is $41.61. The StockSelector Value assumes the market consistently prices a stock around a given PE ratio and, therefore, multiplies the average PE (using forward earnings estimates) over the past three years by future earnings estimates. Among companies with a StockSelector Value above the current stock price, Pfizer is ranked 1573.
Up EPS Surprise
Pfizer beat the consensus earnings estimate when it last reported quarterly earnings.
Historic Revenue Growth
Pfizer rank is 2786
Negative Rankings
Missed Whisper
According to EarningsWhispers.com, Pfizer missed the Earnings Whisper number when it last reported earnings. Statistics show that companies that have missed the Earnings Whisper number underperform the market in the short-term.
Negative Revenue Estimate
Pfizer rank is 385
Negative Guidance
Within the past 90 days Pfizer has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term.
Down Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have decreased by a combined (.34%). Among companies that have had their estimates lowerec within the past month, Pfizer is ranked 716.
10 Day Loss
Pfizer rank is 752
90 Day Loss
Pfizer rank is 770
Negative Cash Growth
Pfizer rank is 1135
Price-to-Sales
Pfizer rank is 1191
Price-to-Book
Pfizer rank is 1267
High Put/Call
Pfizer has a high Put/Call ratio of 0.74 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Pfizer is ranked 1365.
High vPut/Call
Pfizer has a high Put/Call ratio of 0.74 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Pfizer is ranked 1751.
Debt-to-Equity
Pfizer rank is 1983







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.